Welcome to our dedicated page for Afya SEC filings (Ticker: AFYA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Afya Limited (AFYA) is a foreign private issuer that reports to the U.S. Securities and Exchange Commission primarily through Form 20‑F and Form 6‑K. This SEC filings page centralizes access to those documents, which provide detailed information on the company’s operations as a medical education group and medical practice solutions provider in Brazil.
Afya’s Form 20‑F annual report contains audited financial statements and extensive narrative disclosures on its three reportable segments: Undergraduate, Continuing Education and Medical Practice Solutions. Investors can review segment definitions, revenue composition, key operational metrics and risk factors related to its physician‑centric ecosystem and Brazilian regulatory environment.
Throughout the year, Afya files multiple Form 6‑K reports. These include unaudited interim condensed consolidated financial statements, press releases announcing quarterly and half‑year financial results, and disclosures on specific corporate events. Examples documented in recent 6‑Ks include new share repurchase programs for Class A common shares, issuance of commercial notes by Afya Participações S.A., repayment of debentures, repurchase and cancellation of Series A perpetual convertible preferred shares, changes to the board of directors, results of the annual general meeting and the engagement of a new independent registered public accounting firm.
For investors analyzing AFYA, these filings are key sources for understanding revenue trends, adjusted EBITDA, net income, capital structure decisions and governance developments. They also provide context on Afya’s medical school seat authorizations and other regulatory milestones in Brazil’s higher education sector.
On Stock Titan, Afya’s SEC filings are updated in line with EDGAR submissions and can be paired with AI‑powered summaries that explain the main points of lengthy documents. Users can quickly identify which filings relate to financial results, capital markets transactions, governance changes or other material events, and then drill down into the full text when deeper analysis is required.
Afya Ltd vice president Junior Lelio de Souza has filed an initial statement of equity holdings. The filing lists stock options over 8,000 Class A common shares per grant at an exercise price of
The filing also shows restricted stock units over 20,000 and 29,400 Class A common shares, which are scheduled to vest in tranches between
Afya Ltd Vice President Basolli Gomiero Mirella filed an initial ownership report showing a mix of common shares, stock options and restricted stock units tied to Class A Common Shares.
The filing lists four stock option grants, each labeled as a right to buy 26,000 Class A Common Shares at an exercise price of 59.4700 (denominated in Brazilian Reais), with expirations on May 1, 2028, May 1, 2029, May 1, 2030 and May 1, 2031. According to the footnotes, these options fully vest and become exercisable three years before their respective expiration dates, subject to continued service.
The report also shows 29,820 Class A Common Shares subject to outstanding RSUs, which are scheduled to vest as to 12,780 shares on May 1, 2026 and 17,040 shares on May 1, 2027, again contingent on continued service. In addition, the Vice President directly holds 35,265 Class A Common Shares as of the reporting date.
Afya Ltd director Marcelo Ken Suhara filed an initial Form 3 reporting his beneficial ownership position in the company. The available data shows no reported transactions, derivative positions, or specific share holdings at this time, indicating this is a baseline regulatory ownership disclosure rather than an active trade report.
Afya Ltd executive Denis Del Bianco, a Vice President, reported his existing equity interests in the company. The filing shows multiple stock option grants over Class A common shares with exercise prices of 62.5900 and 52.0000 (denominated in Brazilian Reais) and staggered vesting and expiration dates through
Afya Ltd director Joao Paulo Seibel de Faria has filed an initial insider ownership report with no transactions disclosed. The filing shows no reported purchases, sales, exercises, gifts, tax withholdings, restructurings, or derivative positions, serving mainly as a baseline registration of his status as a director.
Afya Ltd executive Anibal Jose Grifo de Sousa, VP Legal Compliance & Government Relations, filed an initial ownership report showing existing equity interests. He directly holds 50,000 Class A Common Shares.
He also reports multiple stock option grants over Class A Common Shares with exercise prices of 52.0000 and 62.5900, with options vesting three years before their respective expiration dates and exercise prices denominated in Brazilian Reais. In addition, he holds restricted stock units covering 15,000, 2,400 and 13,600 Class A Common Shares that vest between May 1, 2026 and May 1, 2029, subject to continued service.
Afya Ltd controller Welder Ferreira Santos filed an initial statement of holdings showing stock options, restricted stock units (RSUs) and Class A common shares. The filing lists several stock option awards to buy Class A shares at exercise prices of
The holdings also include RSUs covering 5,000 Class A shares that vest in tranches of 500, 1,000, 1,500 and 2,000 shares on
Afya Ltd Vice President Erico Coelho Ribeiro filed an initial ownership report showing direct holdings in common shares and equity awards. He directly holds 25,330 Class A common shares. He also holds restricted stock units covering 23,800 Class A common shares that vest in two tranches, and several stock option grants.
The RSUs will vest as to 10,200 shares on May 1, 2026 and 13,600 shares on May 1, 2027, subject to continued service. Ribeiro also holds three stock option awards, each linked to 20,400 underlying Class A common shares with an exercise price of
Afya Ltd Chief Executive Officer Gibbon Virgilio Deloy Capobianco filed an initial Form 3 detailing his holdings in the company. He reports 158,448 Class A common shares held directly and 200,000 Class A common shares held indirectly through GIBBOAT OVERSEAS LTD, which he solely owns and controls.
The filing also lists multiple stock options to acquire Class A common shares at exercise prices of 62.5900 and 52.0000, denominated in Brazilian Reais, with expirations between May 2029 and May 2033 and vesting beginning three years before each expiration date. In addition, he holds restricted stock units covering 90,000 shares that vest in installments of 9,000, 18,000, 27,000 and 36,000 shares on May 1 of 2026, 2027, 2028 and 2029, plus separate RSU awards for 18,000 and 32,000 shares that vest on May 1, 2026.
Afya Ltd vice president Gustavo De Souza Portes Meirelles reported his initial holdings in Class A Common Shares and equity awards. He holds stock options to acquire 12,000 Class A shares in each of five grants at an exercise price of
He also holds restricted stock units covering 31,500 Class A shares, which are scheduled to vest in tranches of 7,000, 10,500 and 14,000 shares on